201Tl and 99Tcm-human serum albumin for assessment of the effect of hypertensive treatment with angiotensin II infusion on tumour circulation

Nuclear Medicine Communications

Volumn 17, Issue 2, 1996, Pages 160-163

  Kinuya, S ^a   Yokoyama, K ^a   Konishi, S ^a   Hwang, E H ^a   Takayama, T ^a   Michigishi, T ^a   Tonami, N ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN TC 99M; ANGIOTENSIN; THALLIUM 201; ANGIOTENSIN II; DIAGNOSTIC AGENT; MACROSALB TC 99M; THALLIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; SCINTISCANNING; TUMOR BLOOD FLOW; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL NEOPLASM; FEMALE; HYPERTENSION; NUDE MOUSE; VASCULARIZATION;

ANGIOTENSIN II; ANIMALS; FEMALE; HUMANS; HYPERTENSION; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; TECHNETIUM TC 99M AGGREGATED ALBUMIN; THALLIUM RADIOISOTOPES;

EID: 0029665396     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006231-199602000-00011     Document Type: Article

References (15)

1. Suzuki M, Hori K, Abe I et al. A new approach of cancer chemotherapy: Selective enhancement of tumor blood flow with angiotensin II. J Natl Cancer Inst 1981; 67: 663-669.
2. Abe I, Hori K, Saito S et al. Increased intratumor concentration of fluorescein-isothiocyanato-labeled neocarzinostatin in rats under angiotensin-induced hypertension. Jpn J Cancer Res (Gann) 1988; 79: 874-879.
3. Sato H, Hori M, Wakui A. Clinical study on angiotensin-induced hypertension chemotherapy (IHC). Jap J Cancer Chemother 1986; 13: 1439-1447.
4. Baba T, Taniguchi S. Improvement of angiotensin II hypertension cancer chemotherapy. Jpn J Cancer Chemother 1987; 14: 971-977.
5. Wakui A, Sato H. Induced hypertension chemotherapy by angiotensin II for solid tumor. Nippon-Rinsho 1989; 17: 564-569.
6. 201Tl scintigraphy. J Juzen Med Soc 1994; 103: 453-464.
7. Sehweil A, El-Sayed M, Ziada G et al. Thallium-201 kinetics in malignant tumors. J Nucl Med 1986; 27: 1033.
8. Caulser C, Macapinlac H, Healey J et al. The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors. Clin Nucl Med 1992; 17: 565-572.
9. Winchell HS. Mechanisms for localization of radiopharmaceuticals in neoplasms. Sem Nucl Med 1976; 6: 371-396.
10. 201Tl in tumor bearing animals and inflammatory lesion induced animals. Eur J Nucl Med 1987; 12: 567-572.
11. 201Tl uptake in tumors. Eur J Nucl Med 1989; 15: 376-379.
12. 201Tl-chloride. Eur J Nucl Med 1978; 3: 81-86.
13. Douglas WW. Polypeptides - angiotensin, plasma kinins, and others. In: Gilman AG, Goodman LS, Gilman A, eds. The pharmacological basis of therapeutics. New York: Macmillan, 1980: 647-667.
14. Smyth MJ, Pietersz GA, McKenzie IFC. Use of vasoactive agents to increase tumor perfusion and the antitumor efficacy of drug-monoclonal antibody conjugates. J Natl Cancer Inst 1987; 79: 1367-1373.
15. Shultz KR, Badger CC, Dombi GW et al. Effects of interleukin-2 on biodistribution of monoclonal antibody in tumor and normal tissues in mice bearing SL-2 thymoma. J Natl Cancer Inst 1992; 84: 109-113.